ConductScience.org, home

Drug · CHEMBL708

Diseases23

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DiseaseOpen Targets' stageStage reported byReportsOf them trialsIts drugs
schizophreniaApprovalTTD4241https://conductscience.org/library/drugs?q=MONDO_0005090
bipolar disorderPhase 3ClinicalTrials.gov1010https://conductscience.org/library/drugs?q=MONDO_0004985
schizoaffective disorderPhase 3ClinicalTrials.gov99https://conductscience.org/library/drugs?q=MONDO_0005487
bipolar I disorderPhase 3ClinicalTrials.gov66https://conductscience.org/library/drugs?q=EFO_0009963
psychotic disorderApprovalATC65https://conductscience.org/library/drugs?q=MONDO_0005485
major depressive disorderPhase 3ClinicalTrials.gov55https://conductscience.org/library/drugs?q=MONDO_0002009
AgitationPhase 3ClinicalTrials.gov44https://conductscience.org/library/drugs?q=HP_0000713
deliriumPhase 3ClinicalTrials.gov22https://conductscience.org/library/drugs?q=MONDO_0045057
depressive disorderPhase 3ClinicalTrials.gov22https://conductscience.org/library/drugs?q=MONDO_0002050
Borderline personality disorderPhase 2ClinicalTrials.gov11https://conductscience.org/library/drugs?q=HP_0012076
Cognitive impairmentPhase 2ClinicalTrials.gov11https://conductscience.org/library/drugs?q=HP_0100543
Insulin resistanceUnknownClinicalTrials.gov11https://conductscience.org/library/drugs?q=HP_0000855
aggressive behaviorUnknownClinicalTrials.gov11https://conductscience.org/library/drugs?q=EFO_0003015
anxietyPhase 3ClinicalTrials.gov11https://conductscience.org/library/drugs?q=MONDO_0011918
autismPhase 2ClinicalTrials.gov11https://conductscience.org/library/drugs?q=MONDO_0005260
cognitive disorderPhase 2ClinicalTrials.gov11https://conductscience.org/library/drugs?q=MONDO_0002039
metabolic syndromeUnknownClinicalTrials.gov11https://conductscience.org/library/drugs?q=EFO_0000195
opiate dependenceEarly phase 1ClinicalTrials.gov11https://conductscience.org/library/drugs?q=MONDO_0005530
opioid use disorderEarly phase 1ClinicalTrials.gov11https://conductscience.org/library/drugs?q=EFO_0010702
periodontal disorderUnknownClinicalTrials.gov11https://conductscience.org/library/drugs?q=MONDO_0002635

Source Open Targetspipelines-2026-09-18-0.3.1

Sources 7

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ConductCognition's list of its testsOur own data
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL708/diseases